Practice parameter for the diagnosis and management of primary immunodeficiency

Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology

Research output: Contribution to journalArticle

149 Citations (Scopus)

Abstract

The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the diagnosis and management of primary immunodeficiency." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

Original languageEnglish (US)
Pages (from-to)1186-1205
Number of pages20
JournalJournal of Allergy and Clinical Immunology
Volume136
Issue number5
DOIs
StatePublished - Nov 1 2015

Fingerprint

Allergy and Immunology
Hypersensitivity
Asthma
Joints
Advisory Committees
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology (2015). Practice parameter for the diagnosis and management of primary immunodeficiency. Journal of Allergy and Clinical Immunology, 136(5), 1186-1205. https://doi.org/10.1016/j.jaci.2015.04.049

Practice parameter for the diagnosis and management of primary immunodeficiency. / Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology.

In: Journal of Allergy and Clinical Immunology, Vol. 136, No. 5, 01.11.2015, p. 1186-1205.

Research output: Contribution to journalArticle

Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology 2015, 'Practice parameter for the diagnosis and management of primary immunodeficiency', Journal of Allergy and Clinical Immunology, vol. 136, no. 5, pp. 1186-1205. https://doi.org/10.1016/j.jaci.2015.04.049
Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology. Practice parameter for the diagnosis and management of primary immunodeficiency. Journal of Allergy and Clinical Immunology. 2015 Nov 1;136(5):1186-1205. https://doi.org/10.1016/j.jaci.2015.04.049
Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology. / Practice parameter for the diagnosis and management of primary immunodeficiency. In: Journal of Allergy and Clinical Immunology. 2015 ; Vol. 136, No. 5. pp. 1186-1205.
@article{fbfb8e6af739434394c10754725d0db4,
title = "Practice parameter for the diagnosis and management of primary immunodeficiency",
abstract = "The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the {"}Practice parameter for the diagnosis and management of primary immunodeficiency.{"} This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.",
author = "{Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology} and Bonilla, {Francisco A.} and Khan, {David A.} and Ballas, {Zuhair K.} and Javier Chinen and Frank, {Michael M.} and Hsu, {Joyce T.} and Michael Keller and Kobrynski, {Lisa J.} and Komarow, {Hirsh D.} and Bruce Mazer and Robert Nelson and Orange, {Jordan S.} and Routes, {John M.} and Shearer, {William T.} and Sorensen, {Ricardo U.} and Verbsky, {James W.} and Bernstein, {David I.} and Joann Blessing-Moore and David Lang and Nicklas, {Richard A.} and John Oppenheimer and Portnoy, {Jay M.} and Randolph, {Christopher R.} and Diane Schuller and Spector, {Sheldon L.} and Stephen Tilles and Dana Wallace",
year = "2015",
month = "11",
day = "1",
doi = "10.1016/j.jaci.2015.04.049",
language = "English (US)",
volume = "136",
pages = "1186--1205",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Practice parameter for the diagnosis and management of primary immunodeficiency

AU - Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology; the American College of Allergy, Asthma & Immunology; and the Joint Council of Allergy, Asthma & Immunology

AU - Bonilla, Francisco A.

AU - Khan, David A.

AU - Ballas, Zuhair K.

AU - Chinen, Javier

AU - Frank, Michael M.

AU - Hsu, Joyce T.

AU - Keller, Michael

AU - Kobrynski, Lisa J.

AU - Komarow, Hirsh D.

AU - Mazer, Bruce

AU - Nelson, Robert

AU - Orange, Jordan S.

AU - Routes, John M.

AU - Shearer, William T.

AU - Sorensen, Ricardo U.

AU - Verbsky, James W.

AU - Bernstein, David I.

AU - Blessing-Moore, Joann

AU - Lang, David

AU - Nicklas, Richard A.

AU - Oppenheimer, John

AU - Portnoy, Jay M.

AU - Randolph, Christopher R.

AU - Schuller, Diane

AU - Spector, Sheldon L.

AU - Tilles, Stephen

AU - Wallace, Dana

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the diagnosis and management of primary immunodeficiency." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

AB - The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the diagnosis and management of primary immunodeficiency." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.

UR - http://www.scopus.com/inward/record.url?scp=84960964432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960964432&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2015.04.049

DO - 10.1016/j.jaci.2015.04.049

M3 - Article

VL - 136

SP - 1186

EP - 1205

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 5

ER -